Sagimet Biosciences Inc (SGMT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sagimet Biosciences inc   (NASDAQ: SGMT)


Sagimet Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sagimet Biosciences Inc's ROI in the second quarter of 2026?
Sagimet Biosciences Inc recorded a cumulative net loss of $-47 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -31.86%.

Within the Healthcare sector 379 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3608, from total ROI ranking in the first quarter of 2026 at 4247.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -1.44 % -29.66 % -30.01 % -16.19 % 4.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 258 102 111 119 130
Return On Investment (TTM) -31.86 % -37.57 % -40.84 % -42.39 % -39.6 %
SGMT's Overall Ranking # 3608 # 4247 # 3769 # 3760 # 3732
Seq. Investment Change TTM 27.6 % -7.32 % -8.16 % -9.26 % -8.94 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -47 -44 -51 -58 -59

SGMT Company Profile >> Back to SGMT Roi Comparisons >> See Annual SGMT Return On Investment



Return On Investment SGMT's Ranking
Within: No.
Industry # 150
Sector # 380
Overall # 3608

Return On Investment Statistics
High Average Low
-20.44 %
-42.94 %
-167.42 %
(Jun 30 2024)   (Jun 30 2023)



  News about Sagimet Biosciences inc Return on Investment ROI

Sagimet Biosciences Looks to Secure Financial Health with New CFO Appointment

May 6, 2024


SAN MATEO, Calif., May 06, 2024 - Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company specializing in developing groundbreaking fatty acid synthase (FASN) inhibitors to address dysfunctional metabolic and fibrotic pathways, has recently announced the appointment of Thierry Chauche as Chief Financial Officer (CFO). The move comes as Sagimet seeks to strengthen its financial foundations and drive future growth and innovation.
Thierry Chauche brings with him a wealth of experience and expertise in finance. With a successful track record spanning over two decades, Chauche has held several key leadership positions within the healthcare and biotech industry. His strong financial acumen and strategic thinking are expected to play a pivotal role in propelling Sagimet s financial health to new heights.





Financial Statements
Sagimet Biosciences Inc's II. Quarter Investments $ 258 Millions SGMT's Balance sheet
Sagimet Biosciences Inc's II. Quarter Income $ -14 Millions Quarterly SGMT's Income Statement
SGMT's Income by Division See SGMT's Income by Division


SGMT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023

Total Investments in Millions 111 156 91 0 0
Y / Y Investment Growth -28.51 % 71.09 % - - -
Net Income in Millions -51 -46 -28 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -45.82 % -29.25 % -30.61 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SGMT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SGMT's Competitors
Subscribers only: Roi for Sagimet Biosciences Inc's Suppliers
Subscribers only: Return On Investment for SGMT's Customers

Other Ratios
SGMT's Roa SGMT's Inventory Turnover Ratio SGMT's Growth Rates SGMT's Dividend Statistics
SGMT's Profitability Ratios SGMT's Asset Turnover Ratio SGMT's Dividend Growth
SGMT's Roe SGMT's Valuation Ratios SGMT's Financial Strength Ratios SGMT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-05T04:00:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.